Sun.Jan 09, 2022

Abbott CEO Ford showcases new ‘biowearable’ line at CES

Pharma Phorum

US medical device company Abbott has said it plans to launch a new range of ‘biowearable’ health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.

Pheasants lose their cool after fighting

Scienmag

Pheasants lose their cool after fighting Credit: Credit Tim Fawcett Pheasants lose their cool after fighting Pheasants’ heads cool rapidly as they prepare to fight – then heat up afterwards, new research shows.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets

BioTech 365

NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets Evaluation of NBTXR3 for global registration in priority head and neck cancer pathway proceeds with the first European patient randomized … Continue reading → Business Wire

52

Hyperbolic metamaterials: Fusing artificial structures to natural 2D materials

Scienmag

Hyperbolic metamaterials (HMMs), which have an extremely high anisotropy with a hyperbolic dispersion relation, are rising as an innovative method of manipulating light.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

908 Devices Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021

BioTech 365

908 Devices Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021 908 Devices Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021 Full year 2021 revenue growth of at least 54% compared to 2020 BOSTON–(BUSINESS WIRE)–908 … Continue reading → Business Wire

52

Unintended consequences of edicts to wear a mask

Scienmag

University of Leeds Press Release Under embargo until 00.01 (United Kingdom time) on Monday 10 January 2022 Statistical Analysis Unintended consequences of edicts to wear a mask Governments need to be careful about the messaging around compulsory mask wearing to ensure the policy is fully effective, say researchers. When officials in Bangladesh announced a legal […]. Latest News consequences edicts mask unintended wear

More Trending

New £10m centre to explore links between organisms and their microbiomes

Scienmag

The £10m Leverhulme Centre for the Holobiont aims to create a green revolution in agriculture, rescue threatened species, and restore habitats. The Centre, which has been awarded funding over ten years by the Leverhulme Trust, is led by a network of researchers across Imperial College London and includes partners at the Wellcome Sanger Institute, the […]. Latest News 10M Centre Explore links microbiomes organisms

NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021

BioTech 365

NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021 NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021 – Record Q4 Product and Service Revenue of $42 Million, Including GeoMx Revenue of … Continue reading → Business Wire

Psychological distress may lead to more care and high medical costs for adolescent and young adult cancer survivors

Scienmag

New research indicates that psychological distress from cancer and its treatment can cause many adolescent and young adult (AYA) cancer survivors to seek additional care and burden them with considerable medical expenses. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Compared with individuals without a history of […]. Latest News adolescent adult cancer care costs distress high lead medical Psychological survivors young

NanoString Announces Commercial Leadership Transition

BioTech 365

NanoString Announces Commercial Leadership Transition NanoString Announces Commercial Leadership Transition Chad Brown to Retire Following More than Four Successful Years as SVP, Sales & Marketing Genomics and Diagnostics Veteran John D.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

FDA OPDP Look Back at 2021 – The Yawning Gap

Eye on FDA

Once again it was a quiet year with respect to the FDA’s Office of Prescription Drug Programs (OPDP).

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates

BioTech 365

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates – Achieved Full Year 2021 Preliminary … Continue reading → Business Wire

New patent expiration for Allergan drug ALPHAGAN P

Drug Patent Watch

Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…. The post New patent expiration for Allergan drug ALPHAGAN P appeared first on DrugPatentWatch - Make Better Decisions.

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2022

BioTech 365

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2022 Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2022 – Revenue of $1,471.1

52

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Pharma in Brief: The 2021 Year in Review

Pharma in Brief

In this article, the Pharma in Brief team has curated and provided updates on the most significant topics we covered in 2021. Introduction. In 2021, governments advanced major policy initiatives aimed at the COVID-19 pandemic and broader health priorities.

Exelixis Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Provides 2022 Financial Guidance, and Outlines Key Priorities and Milestones for 2022

BioTech 365

Exelixis Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Provides 2022 Financial Guidance, and Outlines Key Priorities and Milestones for 2022 Exelixis Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Provides 2022 Financial Guidance, and Outlines … Continue reading → Business Wire

52

Which pharmaceutical companies have the most drug patents in Malaysia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Malaysia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Malaysia?

Drugs 52

MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference

BioTech 365

DGAP-News: MorphoSys AG / Key word(s): Conference 10.01.2022 / 08:00 The issuer is solely responsible for the content of this announcement. Media Release Planegg/Munich, Germany, January 10, 2022 MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference MorphoSys … Continue reading → EQS Newsfeed

40

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook

BioTech 365

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook Full year 2021 commercial … Continue reading → GlobeNewswire

40

HUTCHMED Initiates Phase I Study of BTK Inhibitor HMPL-760 in Patients with Previously Treated B-Cell Non-Hodgkin Lymphoma in China

BioTech 365

HUTCHMED Initiates Phase I Study of BTK Inhibitor HMPL-760 in Patients with Previously Treated B-Cell Non-Hodgkin Lymphoma in China HUTCHMED Initiates Phase I Study of BTK Inhibitor HMPL-760 in Patients with Previously Treated B-Cell Non-Hodgkin Lymphoma in China — HMPL-760 is the … Continue reading → GlobeNewswire

40

IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Library

BioTech 365

IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Library IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Library Superhero cells are key to the efficacy, potency, and durability of therapies across the human health spectrum BRANFORD, … Continue reading → GlobeNewswire

40

Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform

BioTech 365

Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform … Continue reading → GlobeNewswire

Drugs 40

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

BioTech 365

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop … Continue reading → GlobeNewswire

#news #biotech Neurimmune inks US-$760 deal with AstraZeneca

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Neurimmune inks US-$760 deal with AstraZeneca. from European Biotechnology – first and foremost in European biotech [link].

Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results

BioTech 365

Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results Expects a re-baseline of operations with stable revenue contributions from core products and services business in 2022, guiding to total … Continue reading → GlobeNewswire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

BioTech 365

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results ALISO VIEJO, Calif., 09, 2022 (GLOBE NEWSWIRE) — (NASDAQ: … Continue reading → GlobeNewswire

40